Haha I think @limster expert in NVO.Doing some research on potential pharma companies to buy.
Just curious, People buy NVO for the Ozempic craze? Any risks of competition from other weight-loss drug?
For me my research is purely based on numbers, increasing sales and increasing positive cash flow from operations for past 3 years and 3 quarters, regardless of company and macro background
